Do you want to read an article? Please log in or register.
Efficacy and safety of sacubitril-valsartan in heart failure: a meta-analysis of randomized controlled trials
Heart Failure
Related content
Heart Failure
Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial
JAMA Cardiol.
Butler J, Anstrom KJ, Felker GM, Givertz MM, Kalogeropoulos AP, Konstam MA, Mann DL, Margulies KB, McNulty SE, Mentz RJ, Redfield MM, Tang WHW, Whellan DJ, Shah M, Desvigne-Nickens P, Hernandez AF, Braunwald E; National Heart Lung and Blood Institute Heart Failure Clinical Research Network
doi: 10.1001/
Heart Failure
Exercise-Based Rehabilitation for Heart Failure: Cochrane Systematic Review, Meta-Analysis, and Trial Sequential Analysis
JACC Heart Fail.
Taylor RS, Long L, Mordi IR, Madsen MT, Davies EJ, Dalal H, Rees K, Singh SJ, Gluud C, Zwisler AD
doi: 10.1016/j.jchf.2019.04.023.
Heart Failure
Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure: A Secondary Analysis of the PARADIGM-HF Trial
JAMA Cardiol.
Chandra A, Lewis EF, Claggett BL, Desai AS, Packer M, Zile MR, Swedberg K, Rouleau JL, Shi VC, Lefkowitz MP, Katova T, McMurray JJV, Solomon SD
doi: 10.1001/jamacardio.
Heart Failure
The safety of sacubitril-valsartan for the treatment of chronic heart failure.
Expert Opin Drug Saf.
Tyler JM, Teerlink JR
doi: 10.1080/14740338.2017.
Hypertension
Efficacy and Safety of Quarter-Dose Blood Pressure-Lowering Agents: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Hypertension.
Bennett A, Chow CK, Chou M, Dehbi HM, Webster R, Salam A, Patel A, Neal B, Peiris D, Thakkar J, Chalmers J, Nelson M, Reid C, Hillis GS, Woodward M, Hilmer S, Usherwood T, Thom S, Rodgers A
doi: 10.1161/
COMMENTED
Heart Failure
Effect of sacubitril/valsartan on renal function: a systematic review and meta-analysis of randomized controlled trials
★ 3
Recommended and commented by
Prof. Dr Sacha P. Salzberg, Faculty Member
ESC Heart Fail
Spannella F, Giulietti F, Filipponi A, Sarzani R
doi: 10.1002/ehf2.13002
Atrial Fibrillation
Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure: A Meta-analysis of Randomized Controlled Trials
Ann Intern Med.
Turagam MK, Garg J, Whang W, Sartori S, Koruth JS, Miller MA, Langan N, Sofi A, Gomes A, Choudry S, Dukkipati SR, Reddy VY
doi: 10.7326/M18-0992.
Heart Failure
Initiation of sacubitril/valsartan shortly after hospitalisation for acutely decompensated heart failure in patients with newly diagnosed (de novo) heart failure: a subgroup analysis of the TRANSITION study
Eur J Heart Fail.
Senni M, Wachter R, Witte KK, Straburzynska-Migaj E, Belohlavek J, Fonseca C, Mueller C, Lonn E, Chakrabarti A, Bao W, Noe A, Schwende H, Butylin D, Pascual-Figal D, TRANSITION Investigators.
doi: 10.1002/ejhf.1670.
Atrial FibrillationHeart Failure
Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials
Eur Heart J.
Cleland JGF, Bunting KV, Flather MD, Altman DG, Holmes J, Coats AJS, Manzano L, McMurray JJV, Ruschitzka F, van Veldhuisen DJ, von Lueder TG, Böhm M, Andersson B, Kjekshus J, Packer M, Rigby AS, Rosano G, Wedel H, Hjalmarson Å, Wikstrand J, Kotecha D
doi: 10.1093/